Recently Updated Guidelines
Guidelines for Treatment of Cancer by Type
-
Acute Lymphoblastic Leukemia Version 1.2025
-
Anal Carcinoma Version 4.2025
-
Central Nervous System Cancers Version 1.2025
-
Gestational Trophoblastic Neoplasia Version 3.2025
-
Head and Neck Cancers Version 3.2025
-
Neuroendocrine and Adrenal Tumors Version 2.2025
-
Non-Small Cell Lung Cancer Version 4.2025
-
Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer Version 2.2025
-
Pediatric Hodgkin Lymphoma Version 2.2025
-
Primary Cutaneous Lymphomas Version 3.2025
-
Systemic Light Chain Amyloidosis Version 1.2026
-
T-Cell Lymphomas Version 2.2025
-
Thymomas and Thymic Carcinomas Version 2.2025
-
Wilms Tumor (Nephroblastoma) Version 2.2025
-
NCCN Guidelines with Evidence Blocks - Acute Lymphoblastic Leukemia Version 1.2025
-
NCCN Guidelines with Evidence Blocks - Anal Carcinoma Version 4.2025
-
NCCN Guidelines with Evidence Blocks - Gestational Trophoblastic Neoplasia Version 3.2025
-
NCCN Guidelines with Evidence Blocks - Non-Small Cell Lung Cancer Version 4.2025
-
NCCN Guidelines with Evidence Blocks - Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer Version 2.2025
-
NCCN Guidelines with Evidence Blocks - Pediatric Hodgkin Lymphoma Version 2.2025
-
NCCN Guidelines with Evidence Blocks - Primary Cutaneous Lymphomas Version 3.2025
-
NCCN Guidelines with Evidence Blocks - T-Cell Lymphomas Version 2.2025
-
NCCN Guidelines with Evidence Blocks - Thymomas and Thymic Carcinomas Version 2.2025
Guidelines for Detection, Prevention, & Risk Reduction
-
Colorectal Cancer Screening Version 1.2025
-
Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric Version 1.2025
Guidelines for Supportive Care
-
Adult Cancer Pain Version 2.2025
-
Cancer-Associated Venous Thromboembolic Disease Version 2.2025
-
Hematopoietic Cell Transplantation Version 2.2025
-
Survivorship Version 2.2025